Formulir Kontak

Nama

Email *

Pesan *

Cari Blog Ini

Biomarin Pharmaceutical Earnings Nasdaqbmrn

BioMarin Pharmaceutical Reports Strong Quarterly Earnings

Revenue of $712.03 Million for the Quarter Ended June 2024

Conference Call and Webcast Scheduled Today at 4:30 p.m. ET

BioMarin Pharmaceutical Inc. (BMRN) reported solid financial results for the second quarter of 2024, with revenue totaling $712.03 million.

The company announced that it will hold a conference call and webcast later today at 4:30 p.m. ET to discuss the results in more detail.

Investors can access real-time stock quotes, historical data, and other important information about BMRN on financial news websites and online platforms.


Komentar